We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.

Delisted

MBII was delisted on the 12th of July, 2022.

58 hedge funds and large institutions have $62.3M invested in Marrone Bio Innovations, Inc. in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 21 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

6% more capital invested

Capital invested by funds: $59M → $62.3M (+$3.31M)

4% more funds holding

Funds holding: 5658 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

43% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 21

Holders
58
Holders Change
+2
Holders Change %
+3.57%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
12
Reduced
21
Closed
4
Calls
Puts
Net Calls
Net Calls Change

MBII Hedge Fund Activity: Q3 2020 in Review

58 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2020, worth a combined $62.3M — up 5.6% from $59M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MBII positions and 4 closed out — a net gain of 2 holders — while 12 added to existing stakes and 21 trimmed.

The largest buyer was Ardsley Advisory Partners, adding an estimated $417K. The largest seller was Primecap Management, cutting an estimated $188K.

  • 58 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2020, up from 56 in Q2 2020.
  • Funds reported $62.3M of Marrone Bio Innovations, Inc. stock for Q3 2020, up 5.6% quarter-over-quarter.
  • 6 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2020 and 4 closed out, a net change of +2 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q3 2020 was Ardsley Advisory Partners, an estimated $417K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q3 2020 was Primecap Management, an estimated $188K sold.

Based on aggregated 13F filings for Q3 2020.